Valuation: Celltrion, Inc.

Market Cap 40,730B 29.93B 26.32B 24.89B 22.58B 42.4B 2,873B 42.65B 298B 115B 1,466B 112B 110B 4,711B P/E 2026 *
27x
P/E 2027 * 23.2x
Enterprise Value 42.95B 31.56M 27.76M 26.25M 23.81M 44.72M 3.03B 44.98M 314M 121M 1.55B 119M 116M 4.97B EV / Sales 2026 *
7.78x
EV / Sales 2027 * 6.65x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.44%
1 day+0.51%
1 week-1.71%
Current month-5.61%
1 month-6.50%
3 months+7.47%
6 months-9.12%
Current year+3.43%
1 week 176,800
Extreme 176800
180,700
1 month 174,600
Extreme 174600
191,300
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%-1.71%+5.18%+46.87% 29.93B
+2.64%+6.45%+11.87%+38.40% 49.06B
+0.22%+0.40%+50.91%+37.06% 44.6B
-1.58%+4.66%+359.34%+614.38% 43.24B
+1.70%+0.36%+12.56%+99.27% 41.73B
-0.48%-1.32%+23.98%+150.01% 17.19B
+0.08%+9.03%+8.41% - 15.35B
+1.76%+0.85%+29.13%+48.42% 15.54B
+1.97%-3.17% - - 15.11B
+0.60%+5.58%+98.30%+50.83% 14.06B
Average +0.74%+2.22%+66.63%+135.65% 28.58B
Weighted average by Cap. +0.75%+2.42%+79.22%+155.45%

Financials

2026 *2027 *
Net sales 5,521B 4.06B 3.57B 3.37B 3.06B 5.75B 389B 5.78B 40.4B 15.6B 199B 15.23B 14.9B 639B 6,334B 4.65B 4.09B 3.87B 3.51B 6.59B 447B 6.63B 46.35B 17.9B 228B 17.48B 17.1B 733B
Net income 1,538B 1.13B 994M 940M 852M 1.6B 108B 1.61B 11.25B 4.35B 55.35B 4.24B 4.15B 178B 1,780B 1.31B 1.15B 1.09B 987M 1.85B 126B 1.86B 13.02B 5.03B 64.07B 4.91B 4.8B 206B
Net Debt 2,224B 1.63B 1.44B 1.36B 1.23B 2.31B 157B 2.33B 16.27B 6.28B 80.04B 6.13B 6B 257B 1,371B 1.01B 886M 838M 760M 1.43B 96.68B 1.44B 10.03B 3.87B 49.33B 3.78B 3.7B 159B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-28 ₩178,300.00 +0.51% 267,873
26-09-23 ₩177,400.00 -0.62% 294,934
26-09-22 ₩178,500.00 -1.60% 337,067
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
178,300.00KRW
Average target price
267,786.94KRW
Spread / Average Target
+50.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock